Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
Uptake transporters (e.g., members of the SLC superfamily of solute carriers) and export proteins (e.g., members of the ABC transporter superfamily) are important determinants for the pharmacokinetics of drugs. Alterations of drug transport due to concomitantly administered drugs that interfere with...
Main Authors: | Jörg König, Martin F. Fromm, Sabine Klatt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/3/4/680/ |
Similar Items
-
Assessing <i>Trans</i>-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
by: John T. Powell, et al.
Published: (2023-12-01) -
A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators
by: Yiting Yang, et al.
Published: (2021-05-01) -
Divergent Regulation of OCT and MATE Drug Transporters by Cadmium Exposure
by: Hong Yang, et al.
Published: (2021-04-01) -
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
by: Anne T. Nies, et al.
Published: (2021-03-01) -
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance
by: Zhuo-Xun Wu, et al.
Published: (2020-01-01)